🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
SPR
$SPRB
🔒 US EquitiesSpruce Biosciences Inc
AVG HISTORICAL GAP
-8.66%
MAX GAP RECORD
-77.26%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $SPRB
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$SPRB
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE) |
+0.55%
|
| May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN) |
-1.76%
|
| Mar 09, 2026 Earnings Release 2026-03-09 (BEFORE OPEN) |
-6.09%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (AFTER CLOSE) |
+2.77%
|
| Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE) |
+9.71%
|
| Apr 15, 2025 Earnings Release 2025-04-15 (BEFORE OPEN) |
-41.08%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN) |
-2.44%
|
| Aug 12, 2024 Earnings Release 2024-08-12 (AFTER CLOSE) |
+0.48%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
11.2%
Bullish Gaps (3)
Bearish Gaps (7)
Neutral / Flat (4)
📖 Intelligence Summary
Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗